Bupropion Hydrobromide Patent Expiration
Bupropion Hydrobromide is Used for treating major depressive disorder with once-daily dosing. It was first introduced by Bausch Health Us Llc
Bupropion Hydrobromide Patents
Given below is the list of patents protecting Bupropion Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aplenzin | US7241805 | Modified release formulations of a bupropion salt | Jun 27, 2026 | Bausch |
| Aplenzin | US7569610 | Modified release formulations of a bupropion salt | Jun 27, 2026 | Bausch |
| Aplenzin | US7572935 | Modified release formulations of a bupropion salt | Jun 27, 2026 | Bausch |
| Aplenzin | US7585897 | Modified release formulations of a bupropion salt | Jun 27, 2026 | Bausch |
| Aplenzin | US7645802 | Bupropion hydrobromide and therapeutic applications | Jun 27, 2026 | Bausch |
| Aplenzin | US7649019 | Modified release formulations of a bupropion salt | Jun 27, 2026 | Bausch |
| Aplenzin | US7662407 | Modified release formulations of a bupropion salt | Jun 27, 2026 | Bausch |
| Aplenzin | US7671094 | Bupropion hydrobromide and therapeutic applications | Jun 27, 2026 | Bausch |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳